Skip to main content

Juvenile Spondyloarthropathies

Abstract

Spondyloarthropathy (or spondyloarthritis) can begin in childhood (defined as individuals less than 16 years of age). These diseases are distinct in childhood, when compared with adult-onset disease. Because of overlapping features, especially sacroiliac joint involvement, diagnostic difficulty may arise from Behcet’s disease, as well as familial Mediterranean fever. Despite advances in diagnostic techniques such as magnetic resonance imaging, the diagnosis of juvenile spondyloarthropathy may still be delayed many years from the onset of symptoms. Treatment of juvenile spondyloarthropathy has advanced rapidly in the last several years, with increasing evidence that agents targeting tumor necrosis factor are effective. These agents also have serious complications, including induction of other autoimmune diseases.

This is a preview of subscription content, access via your institution.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27:361–8.

    PubMed  Article  Google Scholar 

  2. Dougados M, van der Linden S, Juhlin R, et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum. 1991;34:1218–27.

    PubMed  Article  CAS  Google Scholar 

  3. • Colbert RA. Classification of juvenile spondyloarthritis: Enthesitis-related arthritis and beyond. Nat Rev Rheumatol. 2010;6:477–85. This article gives a concise summary of classification of juvenile spondyloarthropathy under the International League of Associations for Rheumatology classification of juvenile idiopathic arthritis. Both the good points and deficiencies are noted.

    PubMed  Article  Google Scholar 

  4. Petty RE, Southwood TR, Manners P, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390–2.

    PubMed  Google Scholar 

  5. Horneff G, Burgos-Vargas R. Juvenile idiopathic arthritis. Subgroup characteristics and comparisons between rheumatoid arthritis–like subgroups and ankylosing spondylitis–like subgroups. Clin Exp Rheumatol. 2009;27:S131–8.

    PubMed  CAS  Google Scholar 

  6. Sheerin KA, Giannini EH, Brewer Jr EJ, Barron KS. HLA-B27-associated arthropathy in childhood: long-term clinical and diagnostic outcome. Arthritis Rheum. 1988;31:1165–70.

    PubMed  Article  CAS  Google Scholar 

  7. Flato B, Smerdel A, Johnston V, et al. The influence of patient characteristics, disease variables, and HLA alleles on the development of radiographically evident sacroiliitis in juvenile idiopathic arthritis. Arthritis Rheum. 2002;46:986–94.

    PubMed  Article  Google Scholar 

  8. Burgos-Vargas R, Vazquez-Mellado J. The early clinical recognition of juvenile-onset ankylosing spondylitis and its differentiation from juvenile rheumatoid arthritis. Arthritis Rheum. 1995;38:835–44.

    PubMed  Article  CAS  Google Scholar 

  9. Minden K, Niewerth M, Listing J, et al. Long-term outcome in patients with juvenile idiopathic arthritis. Arthritis Rheum. 2002;46:2392–401.

    PubMed  Article  Google Scholar 

  10. •• Burgos-Vargas R. The assessment of the spondyloarthritis international society concept and criteria for the classification of axial spondyloarthritis and peripheral spondyloarthritis: a critical appraisal for the pediatric rheumatologist. Ped Rheumatol. 2012;10:14. Available at http://www.ped-rheum.com/content/10/1/14. This paper reviews the criteria for juvenile spondyloarthropathy proposed by the SpondyloArthritis International Society. This system groups all HLA-B27-related childhood arthritic disease together, with separate criteria for disease involving peripheral or axial joints. The author proposes that because of similar prognosis and treatment, juvenile spondyloarthropathies should be considered together as a single classification entity.

  11. Hofer M, Southwood TR. Classification of childhood arthritis. Best Prac Res Clin Rheumatol. 2002;16:379–96.

    Google Scholar 

  12. Manners PJ, Bower C. Worldwide prevalence of juvenile arthritis why does it vary so much? J Rheumatol. 2002;29:1520–30.

    PubMed  Google Scholar 

  13. Gomez KS, Raza K, Jones SD, Kennedy LG, Calin A. Juvenile onset ankylosing spondylitis—more girls than we thought? J Rheumatol. 1997;24:735–7.

    PubMed  CAS  Google Scholar 

  14. Burgos-Vargas R, Vazquez-Mellado J, Pacheco-Tena C, Hernandez-Garduno A, Goycochea-Robles MV. A 26 week randomised, double blind, placebo controlled exploratory study of sulfasalazine in juvenile onset spondyloarthropathies. Ann Rheum Dis. 2002;61:941–2.

    PubMed  Article  CAS  Google Scholar 

  15. Wanders A, Heijde D, Landewe R, et al. Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum. 2005;52:1756–65.

    PubMed  Article  CAS  Google Scholar 

  16. Homeff G, Burgos-Vargas R. TNF-alpha antagonists for the treatment of juvenile-onset spondyloarthritides. Clin Exp Rheumatol. 2002;20 Suppl 28:S137–42.

    PubMed  CAS  Google Scholar 

  17. Maghraoui AE, Tabache F, Bezza A, et al. A controlled study of sacroiliitis in Behcet's disease. Clin Rheumatol. 2001;20:189–91.

    PubMed  Article  CAS  Google Scholar 

  18. Radouane A, Oudghiri M, Chakib A, et al. HLA-B*27 allele associated to Behcet's disease and to anterior uveitis in Moroccan patients. Ann Biol Clin. 2011;69:419–24.

    CAS  Google Scholar 

  19. Bettencourt A, Pereira C, Carvalho L, et al. New insights of HLA class I association to Behcet's disease in Portuguese patients. Tissue Antigens. 2008;72:379–82.

    PubMed  Article  CAS  Google Scholar 

  20. Kasifoglu T, Calisir C, Cansu DU, Korkmaz C. The frequency of sacroiliitis in familial Mediterranean fever and the role of HLA-B27 and MEFV mutations in the development of sacroiliitis. Clin Rheumatol. 2009;28:41–6.

    PubMed  Article  Google Scholar 

  21. Cinar M, Dinc A, Simsek I, et al. The rate and significance of Mediterranean fever gene mutations in patients with ankylosing spondylitis: a three-month, longitudinal clinical study. Rheumatol Int. 2008;29:37–42.

    PubMed  Article  Google Scholar 

  22. Ozgocmen S, Ardicoglu O, Kamanli A, et al. Pattern of disease onset, diagnostic delay, and clinical features in juvenile onset and adult onset ankylosing spondylitis. J Rheumatol. 2009;36:2830–33.

    PubMed  Article  Google Scholar 

  23. Marks SH, Barnett M, Calin A. A case–control study of juvenile- and adult-onset ankylosing spondylitis. J Rheumatol. 1982;9:739–41.

    PubMed  CAS  Google Scholar 

  24. Stone M, Warren RW, Bruckel J, et al. Juvenile-onset ankylosing spondylitis is associated with worse functional outcomes than adult-onset ankylosing spondylitis. Arthritis Rheum. 2005;53:445–51.

    PubMed  Article  Google Scholar 

  25. • Maksymowych WP. MRI in ankylosing spondylitis. Curr Opin Rheumatol. 2009;21:313–7. This paper thoroughly reviews the advances made in using MRI in ankylosing spondylitis, but there are no data about children.

    PubMed  Article  Google Scholar 

  26. Madsen KB, Schiottz-Christensen B, Jurik AG. Prognostic significance of magnetic resonance imaging changes of the sacroiliac joints in spondyloarthritis—a followup study. J Rheumatol. 2010;37:1718–27.

    PubMed  Article  Google Scholar 

  27. Bochkova AG, Levshakova AV, Bunchuk NV, Braun J. Spinal inflammation lesions as detected by magnetic resonance imaging in patients with early ankylosing spondylitis are more often observed in posterior structures of the spine. Rheumatology. 2010;49:749–55.

    PubMed  Article  Google Scholar 

  28. Yilmaz MH, Ozbayrak M, Kasapcopur O, et al. Pelvic MRI findings of juvenile-onset ankylosing spondylitis. Clin Rheumatol. 2010;29:1007–13.

    PubMed  Article  Google Scholar 

  29. Bollow M, Biedermann T, Kannenberg J, et al. Use of dynamic magnetic resonance imaging to detect sacroiliitis in HLA-B27 positive and negative children with juvenile arthritides. J Rheumatol. 1998;25:556–64.

    PubMed  CAS  Google Scholar 

  30. • Stoll ML, Bhore R, Dempsey-Robertson M, Punaro M. Spondyloarthritis in a pediatric population: risk factors for sacroiliitis. J Rheumatol. 2010;37:2402–8. This interesting study from the Texas Scottish Rite Hospital for Children and the University of Texas Southwestern studied a large cohort of juvenile spondyloarthropathy. Sacroiliitis was found in about half of 143 patients. Hip disease predicted sacroiliitis, while dactylitis was associated with an absence of sacroiliitis.

    PubMed  Article  Google Scholar 

  31. Spadaro A, Iagnocco A, Baccano G, et al. Sonographic-detected joint effusion compared to physical examination in the assessment of sacroiliac joints in spondyloarthritis. Ann Rheum Dis. 2009;68:1559–63.

    PubMed  Article  CAS  Google Scholar 

  32. Williamson L, Dockerty JL, Dalbeth N, et al. Clinical assessment of sacroiliitis and HLA-B27 are poor predictors of sacroiliitis diagnosed by magnetic resonance imaging in psoriatic arthritis. Rheumatology. 2004;43:85–8.

    PubMed  Article  CAS  Google Scholar 

  33. • Stoll ML, Nigrovic PA, Gotte AC, Punaro M. Clinical comparison of early-onset psoriatic and non-psoriatic oligoarticular juvenile idiopathic arthritis. Clin Exp Rheumatol. 2011;29:582–8. This paper that studies a large group of patients continues the story that psoriatic-related juvenile arthritis is a distinct entity from ologoarticular juvenile idiopathic arthritis.

    PubMed  CAS  Google Scholar 

  34. • Stoll ML, Punaro M. Psoriatic juvenile idiopathic arthritis: a tale of two subgroups. Curr Opin Rheumatol. 2011;23:437–43. A concise review of the clinical heterogeneity of juvenile psoriatic arthritis.

    PubMed  Article  Google Scholar 

  35. • Sieper J. Spondyloarthropathies in 2010: new insights into therapy-TNF blockade and beyond. Nat Rev Rheumatol. 2011;7:78–80. A concise review of the role of anti-TNF therapy in spondyloarthritis

    PubMed  Article  CAS  Google Scholar 

  36. • Otten MH, Prince FH, Twilt M, et al. Tumor necrosis factor–blocking agents for children with enthesitis–related arthritis–data from the Dutch arthritis and biologicals in children register, 1999–2010. J Rheumatol. 2011;38:2258–63. Enthesis-related juvenile idiopathic arthritis responded well to etanercept.

    PubMed  Article  CAS  Google Scholar 

  37. •• Otten MH, Prince FH, Armbrust W, et al. Factors associated with treatment response to etanercept in juvenile idiopathic arthritis. JAMA. 2011;306:2340–7. This large ongoing prospective observational trial of biologics in JIA suggests that etanercept is highly efficacious in juvenile spondyloarthropathy.

    PubMed  Article  CAS  Google Scholar 

  38. Horneff G, De Bock F, Foeldvari I, et al. Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry. Ann Rheum Dis. 2009;68:519–25.

    PubMed  Article  CAS  Google Scholar 

  39. • Dougados M, Combe B, Braun J, et al. A randomised, multicenter, double-blind, placebo-controlled trial of etanercept in adults with refractory heel enthesitis in spondyloarthritis: the HEEL trial. Ann Rheum Dis. 2010;69:1430–5. High-quality evidence in the form of a randomized, double-blind, placebo-controlled trial, that anti-TNF is efficacious for Achilles’ tendon enthesitis. This evidence was obtained entirely in adult patients, however.

    PubMed  Article  CAS  Google Scholar 

  40. van der Heijde D, Landewe R, Einstein S, et al. Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis. Arthritis Rheum. 2008;58:3063–70.

    PubMed  Article  Google Scholar 

  41. •• Oen K, Duffy CM, Tse SM, et al. Early outcomes and improvement of patients with juvenile idiopathic arthritis enrolled in a Canadian multicenter inception cohort. Arthritis Care Res. 2010;62:527–36. This is a study of a very large inception cohort of patients with juvenile idiopathic arthritis.

    Article  Google Scholar 

  42. Hage CA, Bowyer S, Tarvin SE, et al. Recognition, diagnosis, and treatment of histoplasmosis complicating tumor necrosis factor blocker therapy. Clin Infect Dis. 2010;50:85–92.

    PubMed  Article  CAS  Google Scholar 

  43. Smith JA, Kauffman CA. Endemic fungal infections in patients receiving tumour necrosis factor-alpha inhibitor therapy. Drugs. 2009;69:1403–15.

    PubMed  Article  CAS  Google Scholar 

  44. Wetter DA, Davis MD. Lupus-like syndrome attributable to anti-tumor necrosis factor alpha therapy in 14 patients during an 8-year period at Mayo Clinic. Mayo Clin Proc. 2009;84:979–84.

    PubMed  CAS  Google Scholar 

  45. • Solomon AJ, Spain RI, Kruer MC, Bourdette D. Inflammatory neurological disease in patients treated with tumor necrosis factor alpha inhibitors. Mult Scler. 2010;17:1472–87. A nice case series and review of the literature.

    Article  Google Scholar 

  46. Tarkiainen M, Tynjala P, Vahasalo P, Lahdenne P. Occurrence of inflammatory bowel disease in four patients with juvenile idiopathic arthritis receiving etanercept or infliximab. Scand J Rheumatol. 2011;40:150–2.

    PubMed  CAS  Google Scholar 

  47. Gaddy JR, Khan ZZ, Chaser B, Scofield RH. Whipple's disease diagnosis following the use of TNF-a blockade. Rheumatology. 2012;51:946.

    PubMed  Article  Google Scholar 

  48. Kakkassery V, Mergler S, Pleyer U. Anti-TNF-alpha treatment: a possible promoter in endogenous uveitis? observational report on six patients: occurrence of uveitis following etanercept treatment. Curr Eye Res. 2010;35:751–6.

    PubMed  Article  CAS  Google Scholar 

Download references

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R. Hal Scofield.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Scofield, R.H., Sestak, A.L. Juvenile Spondyloarthropathies. Curr Rheumatol Rep 14, 395–401 (2012). https://doi.org/10.1007/s11926-012-0273-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-012-0273-3

Keywords

  • Children
  • Juvenile
  • Ankylosing spondylitis
  • Spondyloarthropathy
  • Tumor necrosis factor
  • Treatment
  • Diagnosis
  • Differential diagnosis